Clinical Trial Update: Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 efficacy and safety study evaluating a new therapeutic strategy for extended-disease small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED